What is primary containment for biohazards?
In the realm of biosafety, primary containment refers to the physical barriers that protect laboratory personnel, the environment, and the public from exposure ...

Author:Jason Peng
Cleanroom Engineering Technology Manager of Deiiang Company.
Product R&D Manager of GDC Inc. Cleanroom Equipment Manufacturing Company.
Executive Director of Guangdong Cleanroom Industry Association of China.
Engaged in R&D of related products for 15 years, with rich relevant technical experience
Containment systems form the operational backbone of pharmaceutical and biomedical cleanrooms, creating physical barriers that prevent cross-contamination during high-risk processes. These engineered solutions protect both products from environmental contaminants and personnel from hazardous substances, complying with iso 14644 and EU GMP Annex 1 requirements. Modern systems integrate mechanical, electronic, and procedural controls to ACHieve <0.1% containment breach rates in critical applications like cytotoxic drug handling and pathogen research.
| Equipment | Function | Key Standards |
|---|---|---|
| Isolator Gloveboxes | Complete physical barrier with negative/positive pressure control | ISO 10648-2 Class 3 |
| Rapid Transfer Ports (RTPs) | Sterile material transfer without exposure | ISO 28640 Alpha/Beta |
| Pass-Through Autoclaves | Bi-directional sterilization with interlocked doors | EN 285 temperature mapping |
| Split Butterfly Valves | Closed-system connections for fluid transfer | ASME BPE-2022 |
| Decontamination Showers | Chemical/UV surface decontamination | ISO 15883 validation |
Differential pressure gradients (10-15 Pa steps) create directional airflow using Magnehelic gauges with 0.1 Pa resolution. In vaccine facilities, pressure cascades ensure Grade B to D zoning compliance, with automated dampers adjusting airflow to maintain containment during door openings. Pressure mapping studies validate uniformity per iso 14644-3:2019 with ≤5% deviation across critical zones.
Closed-system transfer devices (CSTDs) utilize double-membrane RTPs validated for 10-6 integrity failure probability. For high-potency APIs, containment solutions employ split valve technology allowing liquid transfer with <0.01μg/m3 exposure levels. VHP (Vaporized Hydrogen Peroxide) decontamination cycles between transfers ensure 6-log reduction of bioindicators.